Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ang I (1-7)
2. Angiotensin 1-7
3. Angiotensin I (1-7)
4. Angiotensin Ii (1-7)
5. Angiotensin Ii (1-7) Heptapeptide
6. Angiotensin Ii-(1-7)
7. Angiotensin-(1-7)
8. Angiotensin-i (1-7)
9. Txa-127
10. Txa127
1. 51833-78-4
2. Angiotensin 1-7
3. Asp-arg-val-tyr-ile-his-pro
4. Txa127
5. Angiotensin I (1-7)
6. Angiotensin-(1-7)
7. Angiotensin Ii (1-7) Heptapeptide
8. Angiotensin Ii (1-7)
9. 8-des-phe-angiotensin Ii
10. Ang-(1-7)
11. Txa-127
12. 39386-80-6
13. Angiotensin I/ii (1-7)
14. Chebi:55438
15. Ile(5)-angiotensin Ii (1-7)
16. L-alpha-aspartyl-l-arginyl-l-valyl-l-tyrosyl-l-isoleucyl-l-histidyl-l-proline
17. L-aspartyl-l-arginyl-l-valyl-l-tyrosyl-l-isoleucyl-l-histidyl-l-proline
18. (2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic Acid
19. Unii-ij3fuk8mof
20. Angiotensin, Canine, Rat
21. Human Angiotensin-(1-7)
22. 1-7-human Angiotensin Ii
23. Angiotensin Ii, Des-phe(8)-
24. Txa 127
25. Ang-1-7 Acetate
26. Angiotensin(1-7)
27. Mfcd00153513
28. Sh-heptapeptide-13
29. Angiotensini(1-7)
30. Bf-angiotensin 1-7
31. Angiotensin Ii, Des-phenylalanine(8)-
32. Ij3fuk8mof
33. Angiotensin, Canine, Ra
34. Angiotensin I/ii(1-7)
35. Ang 1-7
36. Angiotensin Fragment 1-7
37. 5-ile-angiotensin-(1-7)
38. Angiotensin Peptide (1-7)
39. Gtpl582
40. Ang(1-7)
41. Human Angiotensin Ii (1-7)
42. Angiotensin Ii, 5-l-isoleucine-8-de-l-phenylalanine-
43. Gtpl5578
44. [ile5]angiotensin I (1-7)
45. Angiotensin 1-7 Acetate
46. Chembl3545347
47. Schembl15926158
48. Bdbm85556
49. [125i]ang-(1-7)
50. Txa127; Ang-(1-7)
51. Zinc96077632
52. Akos024456667
53. Cs-3413
54. Db11720
55. Angiotensin Ii, 8-de-l-phenylalanine-
56. Ncgc00167219-01
57. As-76407
58. Hy-12403
59. [125i]angiotensin-(1-7) (human, Mouse, Rat)
60. 833a784
61. A901408
62. Angiotensin I/ii Fragment 1-7 Trifluoroacetate Salt
63. Q27074464
64. Aspartyl-argininyl-valinyl-tyrosinyl-isoleucinyl-histidinyl-proline;angiotensin 1-7
65. (2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-hydroxy-4-oxobutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(3h-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic Acid
66. (s)-1-((6s,9s,12s,15s,18s)-18-((1h-imidazol-4-yl)methyl)-1-amino-6-((s)-2-amino-3-carboxypropanamido)-15-sec-butyl-12-(4-hydroxybenzyl)-1-imino-9-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecane)pyrrolidine-2-carboxylic Acid
Molecular Weight | 899.0 g/mol |
---|---|
Molecular Formula | C41H62N12O11 |
XLogP3 | -3 |
Hydrogen Bond Donor Count | 12 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 25 |
Exact Mass | 898.46610084 g/mol |
Monoisotopic Mass | 898.46610084 g/mol |
Topological Polar Surface Area | 380 Ų |
Heavy Atom Count | 64 |
Formal Charge | 0 |
Complexity | 1660 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ABOUT THIS PAGE
A Angiotensin (1-7) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Angiotensin (1-7), including repackagers and relabelers. The FDA regulates Angiotensin (1-7) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Angiotensin (1-7) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Angiotensin (1-7) supplier is an individual or a company that provides Angiotensin (1-7) active pharmaceutical ingredient (API) or Angiotensin (1-7) finished formulations upon request. The Angiotensin (1-7) suppliers may include Angiotensin (1-7) API manufacturers, exporters, distributors and traders.
Angiotensin (1-7) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Angiotensin (1-7) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Angiotensin (1-7) GMP manufacturer or Angiotensin (1-7) GMP API supplier for your needs.
A Angiotensin (1-7) CoA (Certificate of Analysis) is a formal document that attests to Angiotensin (1-7)'s compliance with Angiotensin (1-7) specifications and serves as a tool for batch-level quality control.
Angiotensin (1-7) CoA mostly includes findings from lab analyses of a specific batch. For each Angiotensin (1-7) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Angiotensin (1-7) may be tested according to a variety of international standards, such as European Pharmacopoeia (Angiotensin (1-7) EP), Angiotensin (1-7) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Angiotensin (1-7) USP).
LOOKING FOR A SUPPLIER?